Nosso grupo organiza mais de 3.000 Séries de conferências Eventos todos os anos nos EUA, Europa e outros países. Ásia com o apoio de mais 1.000 Sociedades e publica mais de 700 Acesso aberto Periódicos que contém mais de 50.000 personalidades eminentes, cientistas de renome como membros do conselho editorial.
Periódicos de acesso aberto ganhando mais leitores e citações
700 periódicos e 15 milhões de leitores Cada periódico está obtendo mais de 25.000 leitores
Joshi Hanumanthachar
Alzheimer’s disease (AD) is one of the most common conditions in elderly people with a high prevalence of dementia at roughly 60 – 80. The pathogenesis of AD was relatively complicated and presently there's no unified conclusion in the academic community, so no efficiently clinical treatment is available. In recent years, with the development of traditional Chinese drug (TCM), experimenters have proposed the idea of relying on TCM to prevent and treat AD based on the specific of multiple targets of TCM. This study reviewed the pathological thesis of AD and the implicit biomarkers set up in the current researches. And the implicit targets of berberine and evodiamine from Evodia rutaecarpa in AD were summarized and further anatomized. A emulsion- targets- pathway network was carried out to clarify the medium of action of berberine and evodiamine for AD. Likewise, the limitations of current inquiries on the TCM and AD were discussed. It's hoped that this review will give some references for development of TCM in the prevention and treatment of AD.